ABSTRACT
Until recently, scepticism was often expressed concerning the feasibility, effectiveness, and long-term results of catheter revascularization for treatment of infrapopliteal disease. Furthermore, endovascular interventions of the tibial arteries are often viewed as high risk and prone to failure, with fear of enduring the consequences of a limb-threatening complication. Therefore the accepted indication for below-knee endovascular interventions remains primarily the treatment of critical or limb-threatening ischemia,1
while isolated infrapopliteal endovascular intervention is rarely indicated in patients with intermittent claudication.2 An additional important indication for below-knee angioplasty is to improve run-off and subsequent long-term patency after femoropopliteal angioplasty/stenting or bypass grafting.
